ロード中...
Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo
Hepatocellular carcinoma (HCC) is a highly lethal malignancy mostly because of metastasis, recurrence and acquired resistance to conventional chemotherapy. Arsenic trioxide (ATO) is successfully used to treat hematological malignancies, and has been proven to trigger apoptosis in HCC cells. However,...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5342569/ https://ncbi.nlm.nih.gov/pubmed/27655700 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12041 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|